Ibrutinib resistance-mechanisms and options in CLL
HTML-код
- Опубликовано: 27 июл 2024
- In this presentation from Lymphoma & Myeloma 2016, Dr. Y. Lynn Wang discusses ibrutinib resistance-mechanisms in the treatment of chronic lymphocytic leukemia (CLL).
Earn CME credit for a related activity at the following location:
elc.imedex.com/ELC/Specialty-S...
© 2016 Imedex, LLC.
Efectos secundarios